These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 2505942
1. Inhibition of human placenta aldose reductase by tannic acid. Sawada H, Hamatake M, Hara A, Nakagawa M, Nakayama T. Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1662-4. PubMed ID: 2505942 [Abstract] [Full Text] [Related]
2. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin. Maragoudakis ME, Wasvary J, Hankin H, Gargiulo P. Mol Pharmacol; 1984 May; 25(3):425-30. PubMed ID: 6427599 [Abstract] [Full Text] [Related]
5. Differences in the susceptibility of various aldose reductases to inhibition. II. Kador PF, Kinoshita JH, Tung WH, Chylack LT. Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903 [Abstract] [Full Text] [Related]
6. Studies on antidiabetic agents. IX. A new aldose reductase inhibitor, AD-5467, and related 1,4-benzoxazine and 1,4-benzothiazine derivatives: synthesis and biological activity. Tawada H, Sugiyama Y, Ikeda H, Yamamoto Y, Meguro K. Chem Pharm Bull (Tokyo); 1990 May; 38(5):1238-45. PubMed ID: 2118427 [Abstract] [Full Text] [Related]
7. Inhibition of aldehyde reductase by aldose reductase inhibitors. Sato S, Kador PF. Biochem Pharmacol; 1990 Sep 01; 40(5):1033-42. PubMed ID: 2117925 [Abstract] [Full Text] [Related]
8. Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil. O'Brien MM, Schofield PJ, Edwards MR. J Neurochem; 1982 Sep 01; 39(3):810-4. PubMed ID: 6808090 [Abstract] [Full Text] [Related]
9. Effects of a new aldose reductase inhibitor on various tissues in vitro. Terashima H, Hama K, Yamamoto R, Tsuboshima M, Kikkawa R, Hatanaka I, Shigeta Y. J Pharmacol Exp Ther; 1984 Apr 01; 229(1):226-30. PubMed ID: 6423811 [Abstract] [Full Text] [Related]
13. Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type. Poulsom R. Biochem Pharmacol; 1987 May 15; 36(10):1577-81. PubMed ID: 3109423 [Abstract] [Full Text] [Related]
15. The kinetic mechanism of human placental aldose reductase and aldehyde reductase II. Bhatnagar A, Das B, Gavva SR, Cook PF, Srivastava SK. Arch Biochem Biophys; 1988 Mar 15; 261(2):264-74. PubMed ID: 3128169 [Abstract] [Full Text] [Related]
17. Inhibition of aldose reductases from rat and bovine lenses by flavonoids. Okuda J, Miwa I, Inagaki K, Horie T, Nakayama M. Biochem Pharmacol; 1982 Dec 01; 31(23):3807-22. PubMed ID: 6818971 [Abstract] [Full Text] [Related]
18. Inhibition of P-glycoprotein function by tannic acid and pentagalloylglucose. Kitagawa S, Nabekura T, Nakamura Y, Takahashi T, Kashiwada Y. J Pharm Pharmacol; 2007 Jul 01; 59(7):965-9. PubMed ID: 17637191 [Abstract] [Full Text] [Related]
19. Inhibition of human lens aldose reductase by flavonoids, sulindac and indomethacin. Chaudhry PS, Cabrera J, Juliani HR, Varma SD. Biochem Pharmacol; 1983 Jul 01; 32(13):1995-8. PubMed ID: 6409111 [Abstract] [Full Text] [Related]
20. Inhibition of aldose reductase by 3',4'-dihydroxyflavones. Okuda J, Miwa I, Inagaki K, Horie T, Nakayama M. Chem Pharm Bull (Tokyo); 1984 Feb 01; 32(2):767-72. PubMed ID: 6428761 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]